These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1267715)

  • 1. Prostaglandins in middle ear effusions.
    Bernstein JM; Okazaki T; Reisman RE
    Arch Otolaryngol; 1976 May; 102(5):257-8. PubMed ID: 1267715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in permeability of the middle ear mucosa. The feasibility of blocking inflammatory mediators.
    Frady RP; Parker WA; Jackson RT
    Arch Otolaryngol; 1977 Jan; 103(1):47-51. PubMed ID: 831698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins and otitis media: studies in the chinchilla.
    Jung TT; Smith DM; Juhn SK; Gerrard JM
    Otolaryngol Head Neck Surg (1979); 1980; 88(3):316-23. PubMed ID: 7402673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins in human middle ear effusions.
    Jackson RT; Waitzman MB; Pickford L; Nathanson SE
    Prostaglandins; 1975 Aug; 10(2):365-71. PubMed ID: 1178914
    [No Abstract]   [Full Text] [Related]  

  • 5. Subepithelial space in otitis media.
    Paparella MM; Sipilä P; Juhn SK; Jung TT
    Laryngoscope; 1985 Apr; 95(4):414-20. PubMed ID: 2984491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins in experimental otitis media.
    Smith DM; Jung TT; Juhn SK; Berlinger NT; Gerrard JM
    Arch Otorhinolaryngol; 1979; 225(3):207-9. PubMed ID: 548009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid metabolites in otitis media pathogenesis.
    Jung TT
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():14-8. PubMed ID: 3132884
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretory otitis media. A review.
    Arbesman CE
    Acta Otorhinolaryngol Belg; 1979; 33(4):464-73. PubMed ID: 575463
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prostaglandin on the composition of chinchilla middle ear effusion.
    Jung TT; Smith DM; Juhn SK; Gerrard JM
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):153-60. PubMed ID: 6778299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of inflammatory mediators on middle ear mucosa. A method for measuring permeability and swelling.
    Dennis RG; Whitmire RN; Jackson RT
    Arch Otolaryngol; 1976 Jul; 102(7):420-4. PubMed ID: 938323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ
    Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):654-9. PubMed ID: 1696441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectrophoretic study of proteins in middle ear effusion. A study of secretory otitis media in children.
    Pahor AL; Sözen N; Beetham R; Raine DN
    J Laryngol Otol; 1976 Nov; 90(11):1033-40. PubMed ID: 1003029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prostaglandins and other arachidonic acid metabolites in experimental otitis media.
    Jung TT; Juhn SK; Gerrard JM
    Prostaglandins Leukot Med; 1982 Mar; 8(3):249-61. PubMed ID: 6952290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin C metabolism in the tympanic membrane in chronic inflammation].
    Yamaguchi M; Asaga H; Hasegawa S; Shimada S
    South Med J; 1970 Sep; 63(9):Suppl:956-7. PubMed ID: 5460105
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-standing otitis media with effusion--a convenient model for the study of antibiotic penetration to respiratory tract secretions.
    Edén T
    Scand J Infect Dis Suppl; 1985; 44():46-51. PubMed ID: 3860937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The penetration of erythromycin into the middle ear.
    Sundberg L; Edén T; Ernstson S
    Infection; 1982; 10 Suppl 2():S102-4. PubMed ID: 7107017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of erythromycin through respiratory mucosa. A study using secretory otitis media as a model.
    Sundberg L; Edén T; Ernstson S; Pahlitzsch R
    Acta Otolaryngol Suppl; 1979; 365():1-17. PubMed ID: 294806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of diffusion of cefuroxime into middle ear effusions of patients with chronic purulent otitis media.
    Martini A; Xerri L
    J Antimicrob Chemother; 1982 Sep; 10(3):197-8. PubMed ID: 7142073
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological mediators of inflammation im middle ear effusions.
    Bernstein JM
    Ann Otol Rhinol Laryngol; 1976; 85(2 Suppl 25 Pt 2):90-6. PubMed ID: 773246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of collagenous protein levels in inflamed middle ear mucosa].
    Durko T; Gryczyński M; Dabrowski R
    Otolaryngol Pol; 1991; 45(3):208-12. PubMed ID: 1896187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.